Xponance Inc. Purchases 1,328 Shares of Danaher Co. (NYSE:DHR)

Xponance Inc. grew its position in shares of Danaher Co. (NYSE:DHR) by 1.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 96,394 shares of the conglomerate’s stock after buying an additional 1,328 shares during the quarter. Xponance Inc.’s holdings in Danaher were worth $22,127,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in DHR. Gilbert & Cook Inc. lifted its position in shares of Danaher by 2.5% during the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after purchasing an additional 42 shares in the last quarter. Grimes & Company Inc. lifted its position in shares of Danaher by 0.6% during the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after purchasing an additional 43 shares in the last quarter. Dakota Community Bank & Trust NA lifted its holdings in Danaher by 16.4% in the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after buying an additional 45 shares during the period. Howard Capital Management Group LLC lifted its holdings in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares during the period. Finally, Wrapmanager Inc. lifted its holdings in Danaher by 3.1% in the third quarter. Wrapmanager Inc. now owns 1,659 shares of the conglomerate’s stock valued at $461,000 after buying an additional 50 shares during the period. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on DHR shares. Citigroup cut their price objective on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. JPMorgan Chase & Co. cut their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Jefferies Financial Group lowered their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Finally, Wells Fargo & Company lowered their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Six equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $277.76.

Danaher Stock Up 1.0 %

Shares of DHR stock opened at $212.78 on Tuesday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market cap of $152.08 billion, a P/E ratio of 40.30, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The stock has a 50 day moving average of $219.57 and a 200 day moving average of $240.07.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business earned $2.09 earnings per share. As a group, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio is 24.24%.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 11.10% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.